Fernanda P. Silveira

University Of Pittsburgh At Pittsburgh

$4,141,926

Attributed

$4,141,926

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $940.3K · FY2007–12

$1M$750K$500K$250K$0

'07

'08

'09

'10

'11

'12

Funding mix

By agency

NIH$3,640,194 · 1

CDC$501,732 · 2

By mechanism

R01$3,640,194 · 1

U01$501,732 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Pallavi Ghosh$3,930,342
Yohei Doi$5,766,320
Yuanpu Peter Di$9,824,961
Alecia Barbara Rokes$96,668
Nicole N Scheff$4,386,699

Others in their field

Top investigators on “Dalbavancin”

Elke Lipka · Tsrl, Inc.$2,995,956
Brian James Werth · University Of Washington$2,644,197
Patrick J Loll · Drexel University$1,164,353
Libin Xu · Vanderbilt University$825,243
Daniel Lyndon Jaffe Thorek · Johns Hopkins University$384,863
Razi Kebriaei · Ohio State University$157,500

Research focus

DalbavancinAffectCritical IllnessColistinAntibioticsAreaAbstractingCountryBacillus (Bacterium)Anti-Bacterial AgentsBacterial InfectionsBacterial ResistanceBaseCarbapenemsCharacteristicsAcinetobacterAsiaClinical EfficacyClinical TreatmentClinical TrialsBacteriaCohortColistimethate SodiumDaptomycin